Respiratory Medicine
Volume 97, Issue 1 , Pages 80-85 , January 2003

Proliferation of type II pneumocytes in the lung biopsy specimens reflecting alveolar damage

  • T HONDA

      Affiliations

    • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan
  • ,
  • H OTA

      Affiliations

    • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan
  • ,
  • Y YAMAZAKI

      Affiliations

    • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan
  • ,
  • A YOSHIZAWA

      Affiliations

    • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan
  • ,
  • K FUJIMOTO

      Affiliations

    • Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
  • ,
  • S SONE

      Affiliations

    • Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan

Received 28 December 2001 ,Accepted 4 June 2002.

References 

    REFERENCES
  1. Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis. 1989;139:373–377
  2. Kohno N, Awaya Y, Oyama T. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis. 1993;148:637–642
  3. Matusiewicz SP, Williamson IJ, Sime PJ. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?. Eur Respir J. 1993;6:1282–1286
  4. Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987;165:731–734
  5. Miller RR, Evans KG. Lung biopsy. In:  Thurlbeck WM,  Churg AM editor. Pathology of the Lung. New York: Thieme Medical Publishers; 1995;
  6. Cherniack RM, Colby TV, Flint A. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991;144:892–900
  7. Evans MJ, Dekker NP, Cabral-Anderson LJ, Freeman G. Quantitation of damage to the alveolar epithelium by means of type 2 cell proliferation. Am Rev Respir Dis. 1978;118:787–790
  8. Kaplan HP, Robinson FR, Kapanci Y, Weibel ER. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. I. Clinical and light microscopic studies. Lab Invest. 1969;20:94–100
  9. Katzenstein A-L A. Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung Disease. Philadelphia: W.B. Saunders Company; 1997;
  10. Kuhn C. Patterns of lung repair. a morphologist's view. Chest. 1991;99:11S–14S
  11. McDonald JA. Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair. Chest. 1991;99:87S–93S
  12. Colby TV, Carrington CB. Interstitial lung disease. In:  Thurlbeck WM,  Churg AM editor. Pathology of the Lung. New York: Thieme Medical Publishers; 1995;
  13. Honda T, Hayasaka M, Hachiya T, Ota H, Katsuyama T. Carbohydrate histochemistry of the apical membranes of Non-ciliated bronchiolar cells and type II pneumocytes in six mammalian species. Acta Histochem Cytochem. 1995;28:107–117
  14. Hayasaka M, Honda T, Kubo K, Sekiguchi M. Proliferation of type II pneumocytes and alteration in their apical surface membrane antigenicity in pulmonary sarcoidosis. Chest. 1999;116:477–483
  15. Honda T, Ishida K, Hayama M, Kubo K, Katsuyama T. Type II pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anat Rec. 2000;258:34–38
  16. Fawcett DW. A Textbook of Histology. London: Chapman & Hall; 1994;
  17. Weiss L, Greep RO. Histology. New York: McGraw-Hill Book Company; 1977;
  18. Muller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology. 1986;160:585–588
  19. Remy JM, Remy J, Giraud F, Wattinne L, Gosselin B. Computed tomography assessment of ground-glass opacity: semiology and significance. J Thorac Imaging. 1993;8:249–264
  20. Mornex JF, Cordier G, Pages J. Activated lung lymphocytes in hypersensitivity pneumonitis. J Allergy Clin Immunol. 1984;74:719–727

 Correspondence should be addressed to: Dr Takayuki Honda, MD, PhD, Department of Laboratory Medicine, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto, 390-8621, Japan. Fax: +80 263 34 5316; E-mail: thondat@hsp.md.shinshu-u.ac.jp

PII: S0954-6111(02)91408-3

doi: 10.1053/rmed.2002.1408

Respiratory Medicine
Volume 97, Issue 1 , Pages 80-85 , January 2003